Concepedia

Metformin therapy is associated with a decrease in plasma plasminogen activator inhibitor-1, lipoprotein(a), and immunoreactive insulin levels in patients with the polycystic ovary syndrome

Elsy Velázquez, Soaira G. Mendoza, Ping Wang, Charles J. Glueck

Metabolism · 1997 · 252 citations · 33 references

Concepts

MedicineEndocrinologyGynecologyMenstrual DisordersMetabolic RegulationReproductive EndocrinologyDiabetes MellitusGynecologic EndocrinologyInsulin ResistanceOvarian DisordersOvarian PhysiologyPolycystic Ovary SyndromePlasminogen ActivatorsPolycystic Ovary Syndrome ComorbidityPolycystic Ovary Syndrome ManagementPolycystic Ovary Syndrome PharmacotherapyPolycystic Ovary Syndrome TreatmentPolycystic Ovary Syndrome-associated Insulin Resistance

References

33

CLINICAL ASSESSMENT OF BODY HAIR GROWTH IN WOMEN

David Ferriman, J. D. GALLWEY · The Journal of Clinical Endocrinology & Metabolism · 1961 · 2.5K citations

Medicine, Dermatology, Endocrinology +13

PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION

Anders Hamsten, Göran Walldius, Alfred Szamosi et al. · The Lancet · 1987 · 1.5K citations

Medicine, Cardiology, Clinical Cardiology +11

Increased Plasma Levels of a Rapid Inhibitor of Tissue Plasminogen Activator in Young Survivors of Myocardial Infarction

Anders Hamsten, Björn Wiman, Ulf dé Fairé et al. · New England Journal of Medicine · 1985 · 1.4K citations

Medicine, Cardiology, Clinical Cardiology +10

Plasminogen activator inhibitors

E.D. Sprengers, C Kluft · Blood · 1987 · 930 citations · Full text

Life Sciences, Pharmacology, Enzymology +12

Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy

Elsy Velázquez, Soaira Mendoza, T Hamer et al. · Metabolism · 1994 · 874 citations

Medicine, Endocrinology, Gynecology +17